Ratios Revealed: Decoding TG Therapeutics Inc (TGTX)’s Financial Health

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

The closing price of TG Therapeutics Inc (NASDAQ: TGTX) was $21.31 for the day, down -4.14% from the previous closing price of $22.23. In other words, the price has decreased by -$4.14 from its previous closing price. On the day, 4.19 million shares were traded. TGTX stock price reached its highest trading level at $22.28 during the session, while it also had its lowest trading level at $21.16.

Ratios:

Our analysis of TGTX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.65. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 3.58. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.63.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on August 02, 2023, Upgraded its rating to Neutral and sets its target price to $12 from $16 previously.

On May 20, 2022, BofA Securities started tracking the stock assigning a Underperform rating and target price of $5.BofA Securities initiated its Underperform rating on May 20, 2022, with a $5 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 20 ’24 when Lonial Sagar sold 16,348 shares for $16.87 per share. The transaction valued at 275,791 led to the insider holds 105,195 shares of the business.

Lonial Sagar sold 9,585 shares of TGTX for $157,098 on Jun 17 ’24. The Director now owns 99,293 shares after completing the transaction at $16.39 per share. On Mar 13 ’24, another insider, Lonial Sagar, who serves as the Director of the company, sold 5,000 shares for $15.94 each. As a result, the insider received 79,675 and left with 108,878 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 3299278336 and an Enterprise Value of 2952596224. As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.51, and their Forward P/E ratio for the next fiscal year is 28.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.52 while its Price-to-Book (P/B) ratio in mrq is 18.58. Its current Enterprise Value per Revenue stands at 8.516 whereas that against EBITDA is 28.946.

Stock Price History:

Over the past 52 weeks, TGTX has reached a high of $26.41, while it has fallen to a 52-week low of $6.46. The 50-Day Moving Average of the stock is -5.05%, while the 200-Day Moving Average is calculated to be 18.28%.

Shares Statistics:

TGTX traded an average of 3.62M shares per day over the past three months and 2374170 shares per day over the past ten days. A total of 151.42M shares are outstanding, with a floating share count of 137.98M. Insiders hold about 10.88% of the company’s shares, while institutions hold 59.33% stake in the company. Shares short for TGTX as of 1726185600 were 29835522 with a Short Ratio of 8.25, compared to 1723680000 on 32716007. Therefore, it implies a Short% of Shares Outstanding of 29835522 and a Short% of Float of 21.3.

Most Popular